Literature DB >> 3685057

Methylphenidate affects strategic choice behavior in normal adult humans.

S R Schroeder1, K Mann-Koepke, C T Gualtieri, D A Eckerman, G R Breese.   

Abstract

The time course of serum concentration and performance on a concurrent probability matching task were evaluated in normal adults receiving 0.15 or 0.3 mg/kg of methylphenidate. The behavioral task, an arcade-like problem-solving game, revealed that drug-treated subjects improved their performance upon repeated testings during pharmacokinetic evaluation at a lower rate than did non-treated controls over the same time span. However, drug-treated subjects failed to adopt the adaptive problem-solving strategies selected by controls.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3685057     DOI: 10.1016/0091-3057(87)90217-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  5 in total

1.  Evaluation of pharmacological treatment of impulsivity in children with attention deficit hyperactivity disorder.

Authors:  Nancy A Neef; David F Bicard; Sayaka Endo; Daniel L Coury; Michael G Aman
Journal:  J Appl Behav Anal       Date:  2005

Review 2.  Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals.

Authors:  M Elizabeth Smith; Martha J Farah
Journal:  Psychol Bull       Date:  2011-09       Impact factor: 17.737

Review 3.  The likelihood of cognitive enhancement.

Authors:  Gary Lynch; Linda C Palmer; Christine M Gall
Journal:  Pharmacol Biochem Behav       Date:  2011-01-06       Impact factor: 3.533

4.  Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  Brain Behav       Date:  2012-07-23       Impact factor: 2.708

5.  Social Policy and Cognitive Enhancement: Lessons from Chess.

Authors:  Emilian Mihailov; Julian Savulescu
Journal:  Neuroethics       Date:  2018-02-22       Impact factor: 1.480

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.